What question did this study set out to answer?

The aim is to discuss the contributions of Melody Hancock to understanding CHARGE syndrome and genetic disease mechanisms.

April 1, 2026Open Access

First person – Melody Hancock

Key Points

The aim is to discuss the contributions of Melody Hancock to understanding CHARGE syndrome and genetic disease mechanisms.
Conducted interviews with first authors of selected papers
Focused on insights related to genetic and molecular analysis
Utilized next-generation sequencing data to investigate disease mechanisms
Identified molecular targets associated with CHARGE syndrome
Provided insights into the role of Chd7 in disease pathogenesis
Highlighted potential therapeutic strategies based on multi-omic data

Abstract

ABSTRACT First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Melody Hancock is first author on ‘ Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes’, published in DMM. Melody is a PhD candidate in the lab of Kurt Marsden at North Carolina State University, Raleigh, NC, USA, investigating the mechanisms that mediate genetic disease pathogenesis by integrating next-generation sequencing (NGS) datasets to aid therapeutic strategies.

First person – Melody Hancock

Key Points

Abstract

Cite This Study